Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Attilio Orazi

Showing results (21-30 of 207) with videos related to

Pageof 21
Sort By:
Hematology/Oncology and Stem Cell Therapy|August 14, 2016
The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosisMarco Pizzi, Usama Gergis, Felicia Chaviano, et al.
Clinical Case Reports|February 18, 2021
Primary pancreatic diffuse large B-cell lymphoma, activated B-cell subtype, diagnosed by endoscopic ultrasound-guided fine needle aspiration-A case report and review of the literatureHeather Jones, Jesse Qiao, Osvaldo Padilla, et al.
Archives of Pathology & Laboratory Medicine|January 5, 2005
Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin d1 expression: a potential diagnostic pitfallDennis P O'Malley, Gail H Vance, Attilio Orazi
British Journal of Haematology|May 3, 2024
Autoimmune myelofibrosis: A Mayo Clinic series of 22 patientsNaseema Gangat, Kaaren Reichard, Attilio Orazi, et al.
International Journal of Laboratory Hematology|December 17, 2019
How I investigate chronic myelomonocytic leukemiaValentina Fabiola Ilenia Sangiorgio, Daniel A Arber, Attilio Orazi
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2015
Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical responseMarco Pizzi, Richard T Silver, Ariella Barel, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 18, 2014
Impact of bone marrow pathology on the clinical management of Philadelphia chromosome-negative myeloproliferative neoplasmsOlga Pozdnyakova, Robert P Hasserjian, Srdan Verstovsek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2005
Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemiaDennis P O'Malley, Attilio Orazi, Mingsheng Wang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 26, 2008
Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexateIoannis Venizelos, Zoi Tatsiou, Thomas G Papathomas, et al.
Leukemia Research|June 17, 2008
Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasmFalko Fend, Thomas Horn, Ina Koch, et al.
Pageof 21

Showing results (21-30 of 207) with videos related to

Sort By:
Pageof 21
Hematology/Oncology and Stem Cell Therapy|August 14, 2016
The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosisMarco Pizzi, Usama Gergis, Felicia Chaviano, et al.
Clinical Case Reports|February 18, 2021
Primary pancreatic diffuse large B-cell lymphoma, activated B-cell subtype, diagnosed by endoscopic ultrasound-guided fine needle aspiration-A case report and review of the literatureHeather Jones, Jesse Qiao, Osvaldo Padilla, et al.
Archives of Pathology & Laboratory Medicine|January 5, 2005
Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin d1 expression: a potential diagnostic pitfallDennis P O'Malley, Gail H Vance, Attilio Orazi
British Journal of Haematology|May 3, 2024
Autoimmune myelofibrosis: A Mayo Clinic series of 22 patientsNaseema Gangat, Kaaren Reichard, Attilio Orazi, et al.
International Journal of Laboratory Hematology|December 17, 2019
How I investigate chronic myelomonocytic leukemiaValentina Fabiola Ilenia Sangiorgio, Daniel A Arber, Attilio Orazi
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2015
Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical responseMarco Pizzi, Richard T Silver, Ariella Barel, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 18, 2014
Impact of bone marrow pathology on the clinical management of Philadelphia chromosome-negative myeloproliferative neoplasmsOlga Pozdnyakova, Robert P Hasserjian, Srdan Verstovsek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 25, 2005
Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemiaDennis P O'Malley, Attilio Orazi, Mingsheng Wang, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 26, 2008
Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexateIoannis Venizelos, Zoi Tatsiou, Thomas G Papathomas, et al.
Leukemia Research|June 17, 2008
Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasmFalko Fend, Thomas Horn, Ina Koch, et al.
Pageof 21